UTI Healthcare Fund
The fund remains heavily concentrated in pharmaceutical stocks, with nearly 69% in drugs and biotech—a sector-specific bet on India's generics and contract manufacturing strength. The manager is selectively rotating within pharma, trimming Lupin while building cash reserves, suggesting cautious positioning amid valuations or near-term headwinds. Strong April returns and modest diversification into healthcare services indicate conviction in the sector's structural growth, though concentration risk remains elevated.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹349.0771 | +8.27% | — | — | — |
| Regular Growth | ₹307.1326 | +8.19% | +12.83% | +27.05% | +14.38% |
| Direct IDCW | ₹269.8111 | +8.27% | — | — | — |
| Regular IDCW | ₹237.3706 | +8.19% | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight | |
|---|---|---|
| No new entries this month | ||
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | EQ - SUN PHARMACEUTICALS INDUSTRIES INE044A01036 | 9.49% |
| 2 | EQ - AJANTA PHARMA LTD. INE031B01049 | 5.84% |
| 3 | NET CURRENT ASSETS | 4.74% |
| 4 | EQ - LUPIN LTD. INE326A01037 | 4.23% |
| 5 | EQ - APOLLO HOSPITALS ENTERPRISE LT INE437A01024 | 3.54% |
| 6 | EQ - DIVIS LABORATORIES LTD. INE361B01024 | 3.45% |
| 7 | EQ - DR REDDYS LABORATORIES LTD. INE089A01031 | 3.35% |
| 8 | EQ - GLENMARK PHARMACEUTICALS LTD. INE935A01035 | 3.35% |
| 9 | EQ - GLAND PHARMA LTD. INE068V01023 | 3.30% |
| 10 | EQ - FORTIS HEALTHCARE LTD. INE061F01013 | 3.23% |
| 11 | EQ - ALKEM LABORATORIES LTD INE540L01014 | 3.21% |
| 12 | EQ - MAX HEALTHCARE INSTITUTE LTD INE027H01010 | 3.00% |
| 13 | EQ - COHANCE LIFESCIENCES LIMITED INE03QK01018 | 2.96% |
| 14 | EQ - ANTHEM BIOSCIENCES LTD INE0CZ201020 | 2.48% |
| 15 | EQ - AUROBINDO PHARMA LTD. INE406A01037 | 2.46% |
| 16 | EQ - PROCTOR & GAMBLE HEALTH LTD INE199A01012 | 2.28% |
| 17 | EQ - IPCA LABORATORIES LTD. INE571A01038 | 2.19% |
| 18 | EQ - CAPLIN POINT LABORATORIES LTD INE475E01026 | 2.17% |
| 19 | EQ - SAI LIFE SCIENCES LTD INE570L01029 | 2.15% |
| 20 | EQ- GLOBAL HEALTH LTD. INE474Q01031 | 2.06% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does UTI Healthcare Fund hold?
UTI Healthcare Fund holds 44 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 26.55% of NAV.
What is the largest holding in UTI Healthcare Fund?
The largest position in UTI Healthcare Fund is EQ - SUN PHARMACEUTICALS INDUSTRIES, accounting for 9.49% of NAV in the Pharmaceuticals & Biotechnology sector.
Is UTI Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.356, UTI Healthcare Fund is well-diversified. The HHI concentration index is 31,846 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 26.55% of the portfolio.
What is the market cap allocation of UTI Healthcare Fund?
Based on SEBI's AMFI classification, UTI Healthcare Fund's equity portfolio is split as: Large Cap: 24.55%, Mid Cap: 23.84%, Small Cap: 46.88%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does UTI Healthcare Fund invest in most?
UTI Healthcare Fund has the highest allocation to Pharmaceuticals & Biotechnology (68.83%), Healthcare Services (23.47%), Chemicals & Petrochemicals (1.99%). The fund is invested across 5 sectors in total.
How actively managed is UTI Healthcare Fund compared to other Sectoral / Thematic funds?
UTI Healthcare Fund has an Active Share of 87.79%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.